Biopharmas raising money in public or private financings, including: Myosin, Novan, Onkosxcel, Protai.

Med-tech firms raising money in public or private financings, including: Synaptive Medical.

Biopharmas in Asia-Pacific raising money in public or private financings: Allorion, Kyowa Kirin, Opthea, Ring.

Biopharmas raising money in public or private financings, including: Adamis, Algotx, Betterlife, Okyo, Switch.

Teitur Trophics ApS, a spinout from Aarhus University seeded by the Bioinnovation Institute in 2020, has completed a €28 million (US$30.1 million) series A financing. Teitur has developed a platform of first-in-class cyclic peptides with a novel mechanism that preserves neuronal function, and these peptides have the potential to treat a broad range of neurodegenerative diseases.

Siyi Intelligence Technology Co. Ltd. raised nearly $15 million in a series A funding round to speed up the development of its smart rehabilitation products and of its neurorehabilitation solutions and build a digital rehabilitation service platform.

Biopharmas raising money in public or private financings, including: Ambrx, First Wave, Shennon.

Med-tech firms raising money in public or private financings, including: Sunrise.